Advertisement

InVivo Therapeutics Holdings Corp. (OTCBB: NVIV), a life sciences company focused on potential treatments for spinal cord injuries, has entered into a six-year lease for a new 21,000 square-foot headquarters at One Kendall Square in Cambridge.

SOURCE

Advertisement
Advertisement